Ascentage Pharma Group International (AAPG) has been capturing the attention of investors with its promising pipeline and robust potential upside of 91.92%. Operating in the biotechnology sector of the healthcare..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) operates at the cutting edge of biotechnology, merging biology and chemistry with advanced data science and engineering to revolutionize drug discovery. Based in Salt Lake..
Centessa Pharmaceuticals plc (NASDAQ: CNTA) stands as a compelling opportunity within the biotechnology sector, appealing to investors with its strong potential upside of 60.32%. Despite its relatively recent inception in..
Investors with an eye on the biotechnology sector may find Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) an intriguing prospect. With a robust market capitalization of $6.17 billion and a focus on..
Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, stands out with a robust market cap of $1.82 billion. As a commercial-stage biopharmaceutical company, Vericel is at the..
Belite Bio, Inc (NASDAQ: BLTE), a dynamic player in the biotechnology sector, has captured the attention of investors with its promising clinical-stage drug development efforts focused on retinal degenerative eye..
For investors with an eye on the healthcare technology sector, Certara, Inc. (NASDAQ: CERT) presents an intriguing proposition. With a current market cap of $1.05 billion, this U.S.-based company is..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of investors with its promising growth prospects and a compelling potential upside. As a prominent player in the healthcare sector, specifically..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a noteworthy player in the biotechnology sector, with a focus on developing and commercializing innovative therapeutic compounds. Headquartered in Waltham, Massachusetts, Apellis operates within..
BGM Group Ltd. (BGM), a player in the healthcare sector specializing in active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives, has recently caught the attention of investors. Based in..
Galapagos NV (NASDAQ: GLPG), a biotechnology firm hailing from Belgium, is capturing investor attention not only for its innovative medical advancements but also for the financial challenges it currently faces...
Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotech sector, thanks to its robust pipeline of innovative drug candidates and an impressive potential upside of 219.73%, as..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative approach to urologic surgery. Specializing in surgical robotics, this San Jose-based company is gaining attention..
Alignment Healthcare, Inc. (ALHC), a key player in the healthcare plans industry, has been capturing investor attention with its remarkable revenue growth and a promising potential upside. Based in Orange,..
Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a diverse array of solutions aimed at enhancing provider performance, optimizing supply chains, and fostering value-based care...
GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $2.61 billion, this Stamford,..
Scholar Rock Holding Corporation (NASDAQ: SRRK) is a notable player in the biotechnology sector, engaging in pioneering work to develop treatments targeting serious diseases influenced by protein growth factor signaling...
Warby Parker Inc. (NYSE: WRBY) stands out in the healthcare sector with its innovative approach to eyewear retail. As a prominent player in the medical instruments and supplies industry, the..
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a standout player in the dynamic biotechnology sector, offering a diverse portfolio of licensed biopharmaceutical assets. Based in Jupiter, Florida, Ligand is a significant..
Clover Health Investments, Corp (NASDAQ: CLOV) has been catching the attention of investors with its promising 60.07% potential upside, according to recent analyst ratings. Specializing in Medicare Advantage plans across..
